SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Omega Healthcare Investors Inc. – ‘10-K’ for 12/31/21 – ‘EX-10.6N’

On:  Thursday, 2/17/22, at 11:30am ET   ·   For:  12/31/21   ·   Accession #:  888491-22-7   ·   File #:  1-11316

Previous ‘10-K’:  ‘10-K’ on 2/22/21 for 12/31/20   ·   Next:  ‘10-K’ on 2/14/23 for 12/31/22   ·   Latest:  ‘10-K’ on 2/12/24 for 12/31/23   ·   47 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/17/22  Omega Healthcare Investors Inc.   10-K       12/31/21  155:28M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.43M 
 8: EX-10.10    Material Contract                                   HTML     47K 
 2: EX-10.6M    Material Contract                                   HTML    100K 
 3: EX-10.6N    Material Contract                                   HTML    116K 
 4: EX-10.6O    Material Contract                                   HTML    108K 
 5: EX-10.6P    Material Contract                                   HTML    125K 
 6: EX-10.6Q    Material Contract                                   HTML    108K 
 7: EX-10.6R    Material Contract                                   HTML    124K 
 9: EX-21.1     Subsidiaries List                                   HTML    199K 
10: EX-22.1     Published Report re: Matters Submitted to a Vote    HTML     41K 
                of Security Holders                                              
11: EX-23.1     Consent of Expert or Counsel                        HTML     41K 
12: EX-31.1     Certification -- §302 - SOA'02                      HTML     45K 
13: EX-31.2     Certification -- §302 - SOA'02                      HTML     45K 
14: EX-32.1     Certification -- §906 - SOA'02                      HTML     42K 
15: EX-32.2     Certification -- §906 - SOA'02                      HTML     41K 
21: R1          Document and Entity Information                     HTML    107K 
22: R2          Consolidated Balance Sheets                         HTML    162K 
23: R3          Consolidated Balance Sheets (Parentheticals)        HTML     57K 
24: R4          Consolidated Statements of Operations               HTML    141K 
25: R5          Consolidated Statements of Comprehensive Income     HTML     72K 
                (Loss)                                                           
26: R6          Consolidated Statements of Changes in Equity        HTML    117K 
27: R7          Consolidated Statements of Changes in Equity        HTML     42K 
                (Parentheticals)                                                 
28: R8          Consolidated Statements of Cash Flows               HTML    158K 
29: R9          Organization                                        HTML     45K 
30: R10         Summary of Significant Accounting Policies          HTML    131K 
31: R11         Real Estate Acquisitions                            HTML    179K 
32: R12         Assets Held for Sale, Dispositions and Impairments  HTML     55K 
33: R13         Contractual Receivables and Other Receivables and   HTML     79K 
                Lease Inducements                                                
34: R14         Leases                                              HTML    106K 
35: R15         Mortgage Notes Receivable                           HTML     84K 
36: R16         Other Investments                                   HTML     83K 
37: R17         Allowance for Credit Losses                         HTML    332K 
38: R18         Variable Interest Entities                          HTML    114K 
39: R19         Investment in Joint Ventures                        HTML    125K 
40: R20         Goodwill and Other Intangibles                      HTML     73K 
41: R21         Concentration of Risk                               HTML     44K 
42: R22         Borrowing Arrangements                              HTML    193K 
43: R23         Derivatives and Hedging                             HTML     60K 
44: R24         Financial Instruments                               HTML    134K 
45: R25         Taxes                                               HTML     82K 
46: R26         Stockholders Equity                                 HTML    154K 
47: R27         Stock-Based Compensation                            HTML    147K 
48: R28         Commitments and Contingencies                       HTML     67K 
49: R29         Supplemental Disclosure to Consolidated Statements  HTML    116K 
                of Cash Flows                                                    
50: R30         Earnings Per Share                                  HTML     87K 
51: R31         Subsequent Events                                   HTML     47K 
52: R32         Schedule Ii - Valuation and Qualifying Accounts     HTML     75K 
53: R33         Schedule Iii - Real Estate and Accumulated          HTML    461K 
                Depreciation                                                     
54: R34         Schedule Iv - Mortgage Loans on Real Estate         HTML    292K 
55: R35         Summary of Significant Accounting Policies          HTML    197K 
                (Policies)                                                       
56: R36         Summary of Significant Accounting Policies          HTML     55K 
                (Tables)                                                         
57: R37         Real Estate Acquisitions (Tables)                   HTML    180K 
58: R38         Assets Held for Sale, Dispositions and Impairments  HTML     49K 
                (Tables)                                                         
59: R39         Contractual Receivables and Other Receivables and   HTML     60K 
                Lease Inducements (Tables)                                       
60: R40         Leases (Tables)                                     HTML    108K 
61: R41         Mortgage Notes Receivable (Tables)                  HTML     65K 
62: R42         Other Investments (Tables)                          HTML     68K 
63: R43         Allowance for Credit Losses (Tables)                HTML    419K 
64: R44         Variable Interest Entities (Tables)                 HTML    118K 
65: R45         Investment in Joint Ventures (Tables)               HTML    123K 
66: R46         Goodwill and Other Intangibles (Tables)             HTML     74K 
67: R47         Borrowing Arrangements (Tables)                     HTML    179K 
68: R48         Derivatives and Hedging (Tables)                    HTML     53K 
69: R49         Financial Instruments (Tables)                      HTML    126K 
70: R50         Taxes (Tables)                                      HTML     79K 
71: R51         Stockholders Equity (Tables)                        HTML    151K 
72: R52         Stock-Based Compensation (Tables)                   HTML    139K 
73: R53         Commitments and Contingencies (Tables)              HTML     51K 
74: R54         Supplemental Disclosure to Consolidated Statements  HTML    115K 
                of Cash Flows (Tables)                                           
75: R55         Earnings Per Share (Tables)                         HTML     86K 
76: R56         Organization and Basis of Presentation (Details)    HTML     45K 
77: R57         Summary of Significant Accounting Policies          HTML    229K 
                (Narrative) (Detail)                                             
78: R58         Summary of Significant Accounting Policies          HTML     54K 
                (Schedule of credit losses impact) (Detail)                      
79: R59         Real Estate Acquisitions (Narrative) (Details)      HTML     87K 
80: R60         Real Estate Acquisitions (Schedule of Significant   HTML    147K 
                Acquisitions) (Detail)                                           
81: R61         Real Estate Acquisitions (Encore Portfolio)         HTML     52K 
                (Narrative) (Detail)                                             
82: R62         Real Estate Acquisitions (MedEquities Merger)       HTML     86K 
                (Narrative) (Detail)                                             
83: R63         Real Estate Acquisitions (Pro Forma Acquisition     HTML     57K 
                Results) (Detail)                                                
84: R64         Real Estate Acquisitions (Fair Value of Assets      HTML     87K 
                Acquired and Liabilities Assumed) (Detail)                       
85: R65         Assets Held for Sale, Dispositions and Impairments  HTML     99K 
                (Narrative) (Details)                                            
86: R66         Assets Held for Sale, Dispositions and Impairments  HTML     43K 
                (Schedule of Properties Held-for-Sale) (Details)                 
87: R67         Contractual Receivables and Other Receivables and   HTML    290K 
                Lease Inducements (Narrative) (Details)                          
88: R68         Contractual Receivables and Other Receivables and   HTML     51K 
                Lease Inducements (Schedule of Net Accounts                      
                Receivable) (Detail)                                             
89: R69         Leases (Narrative) (Detail)                         HTML    109K 
90: R70         Leases (Schedule of operating lease income)         HTML     47K 
                (Details)                                                        
91: R71         Leases (Schedule of estimated contractual rents     HTML     54K 
                due under operating leases) (Details)                            
92: R72         Leases - Balance sheet information (Details)        HTML     48K 
93: R73         Leases (Schedule of Components of Investment in     HTML     58K 
                Direct Financing Leases) (Detail)                                
94: R74         Mortgage Notes Receivable (Narrative) (Detail)      HTML     58K 
95: R75         Mortgage Notes Receivable (Schedule of              HTML     93K 
                Receivables) (Detail)                                            
96: R76         Mortgage Notes Receivable (Notes Due 2027           HTML    115K 
                Narrative) (Detail)                                              
97: R77         Mortgage Notes Receivable (Notes Due 2029           HTML    172K 
                Narrative) (Detail)                                              
98: R78         Mortgage Notes Receivable (Other Mortgage Notes     HTML     88K 
                Outstanding) (Narrative) (Details)                               
99: R79         Other Investments (Schedule of Receivables)         HTML    103K 
                (Details)                                                        
100: R80         Other Investments (Notes Due 2024 Narrative)        HTML     71K  
                (Detail)                                                         
101: R81         Other Investments (Other investments notes due      HTML     77K  
                2024-2025) (Narrative) (Details)                                 
102: R82         Other Investments (Notes Due 2023 Narrative)        HTML     57K  
                (Detail)                                                         
103: R83         Other Investments (Notes Due 2030 Narrative)        HTML     61K  
                (Detail)                                                         
104: R84         Other Investments (Other Investment Note            HTML    126K  
                Narrative) (Detail)                                              
105: R85         Allowance for Credit Losses (Narrative) (Detail)    HTML     63K  
106: R86         Allowance for Credit Losses (Schedule of expected   HTML    185K  
                credit loss per segment) (Detail)                                
107: R87         Allowance for Credit Losses (Schedule by segment    HTML     96K  
                balance by vintage and credit quality indicator)                 
                (Detail)                                                         
108: R88         Variable Interest Entities (Schedule of Variable    HTML    138K  
                Interest Entities) (Detail)                                      
109: R89         Investment in Joint Ventures (Narrative) (Details)  HTML     47K  
110: R90         Investment in Joint Ventures (Schedule of equity    HTML    171K  
                method investments) (Details)                                    
111: R91         Goodwill and Other Intangibles (Narrative)          HTML     56K  
                (Details)                                                        
112: R92         Goodwill and Other Intangibles (Schedule of         HTML     45K  
                Reconciliation of Goodwill) (Detail)                             
113: R93         Goodwill and Other Intangibles (Schedule of         HTML     53K  
                Intangibles) (Detail)                                            
114: R94         Concentration of Risk (Narrative) (Detail)          HTML    101K  
115: R95         Borrowing Arrangements (Schedule of Borrowings)     HTML    223K  
                (Details)                                                        
116: R96         Borrowing Arrangements (HUD Mortgage) (Details)     HTML     81K  
117: R97         Borrowing Arrangements (Revolving Credit Facility)  HTML     62K  
                (Details)                                                        
118: R98         Borrowing Arrangements (OP Term Loan) (Details)     HTML     64K  
119: R99         Borrowing Arrangements (Omega Credit Facilities,    HTML    131K  
                OP Term Loan, Amended 2015 Term Loan Facilities                  
                and General) (Detail)                                            
120: R100        Borrowing Arrangements (Subordinated Debt)          HTML     59K  
                (Narrative) (Detail)                                             
121: R101        Borrowing Arrangements (Schedule of principal       HTML     58K  
                payments, excluding the premium or discount and                  
                the aggregate due thereafter) (Detail)                           
122: R102        Derivatives and Hedging (Narrative) (Details)       HTML    128K  
123: R103        Derivatives and Hedging (Location and the fair      HTML     50K  
                value of derivative instruments designated as                    
                hedges) (Details)                                                
124: R104        Financial Instruments (Schedule of Financial        HTML    124K  
                Instruments) (Details)                                           
125: R105        Taxes (Narrative) (Detail)                          HTML     51K  
126: R106        Taxes (Schedule of components of income tax         HTML     46K  
                expense) (Details)                                               
127: R107        Taxes (Schedule of deferred tax assets and          HTML     49K  
                liabilities) (Detail)                                            
128: R108        Stockholders Equity (Forward Equity Offering)       HTML     54K  
                (Narrative) (Detail)                                             
129: R109        Stockholders Equity (Common Stock Repurchase)       HTML     44K  
                (Narrative) (Detail)                                             
130: R110        Stockholders Equity (At The Market Program          HTML     60K  
                Schedule and Narrative) (Detail)                                 
131: R111        Stockholders Equity (Schedule of dividend           HTML     43K  
                reinvestment and common stock purchase plan)                     
                (Detail)                                                         
132: R112        Stockholders Equity (Schedule of Common Stock       HTML     46K  
                Dividends) (Details)                                             
133: R113        Stockholders Equity (Per Share Distributions)       HTML     48K  
                (Detail)                                                         
134: R114        Stockholders Equity (Schedule of Accumulated Other  HTML    105K  
                Comprehensive Income (Loss)) (Details)                           
135: R115        Stock-Based Compensation (Narrative) (Detail)       HTML     81K  
136: R116        Stock-Based Compensation (Schedule of assumptions   HTML     54K  
                used for estimating fair value of stock awards                   
                using Monte-Carlo model) (Detail)                                
137: R117        Stock-Based Compensation (Schedule of activity in   HTML     81K  
                restricted stock and RSUs) (Detail)                              
138: R118        Commitments and Contingencies (Narrative)           HTML     59K  
                (Details)                                                        
139: R119        Commitments and Contingencies (Schedule of          HTML     47K  
                remaining commitments) (Detail)                                  
140: R120        Supplemental Disclosure to Consolidated Statements  HTML     93K  
                of Cash Flows (Detail)                                           
141: R121        Earnings Per Share (Schedule of Computation of      HTML     91K  
                Basic and Diluted Earnings per Share) (Detail)                   
142: R122        Earnings Per Share (Narrative) (Detail)             HTML     54K  
143: R123        Subsequent Event (Narrative) (Details)              HTML    109K  
144: R124        Schedule Ii - Valuation and Qualifying Accounts     HTML     54K  
                (Detail)                                                         
145: R125        Schedule Iii - Real Estate and Accumulated          HTML    417K  
                Depreciation (Detail)                                            
146: R126        Schedule Iii - Real Estate and Accumulated          HTML     62K  
                Depreciation (Narrative) (Detail)                                
147: R127        Schedule Iii - Real Estate and Accumulated          HTML     51K  
                Depreciation (Narrative 1) (Detail)                              
148: R128        Schedule Iv - Mortgage Loans on Real Estate         HTML    197K  
                (Detail)                                                         
149: R129        Schedule Iv - Mortgage Loans on Real Estate         HTML     56K  
                (Narrative 1) (Detail)                                           
150: R130        Schedule Iv - Mortgage Loans on Real Estate         HTML     44K  
                (Narrative 2) (Detail)                                           
153: XML         IDEA XML File -- Filing Summary                      XML    297K  
151: XML         XBRL Instance -- ohi-20211231x10k_htm                XML   8.35M  
152: EXCEL       IDEA Workbook of Financial Reports                  XLSX    262K  
17: EX-101.CAL  XBRL Calculations -- ohi-20211231_cal                XML    310K 
18: EX-101.DEF  XBRL Definitions -- ohi-20211231_def                 XML   2.14M 
19: EX-101.LAB  XBRL Labels -- ohi-20211231_lab                      XML   2.42M 
20: EX-101.PRE  XBRL Presentations -- ohi-20211231_pre               XML   2.82M 
16: EX-101.SCH  XBRL Schema -- ohi-20211231                          XSD    468K 
154: JSON        XBRL Instance as JSON Data -- MetaLinks              761±  1.18M  
155: ZIP         XBRL Zipped Folder -- 0000888491-22-000007-xbrl      Zip    856K  


‘EX-10.6N’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  C:  <!  <> 

2022 FORM OF

TIME-BASED PROFITS INTEREST UNITS AGREEMENT
PURSUANT TO
THE OMEGA HEALTHCARE INVESTORS, INC. 2018 STOCK INCENTIVE PLAN

THIS AGREEMENT (this “Agreement”) is made as of the Grant Date, by and between OHI Healthcare Properties Limited Partnership (the “Partnership”), a limited partnership controlled by, and an Affiliate (as defined below) of, Omega Healthcare Investors, Inc. (Omega Healthcare Investors, Inc. is hereafter referred to as the “Company”) and  _____________________ (the “Recipient”).

Upon and subject to this Agreement (including the Terms and Conditions and the Exhibits which are attached hereto and incorporated herein as part of this Agreement) and the Limited Partnership Agreement (as defined herein), the Partnership hereby awards as of the Grant Date to the Recipient the number of Profits Interest Units set forth below (the “Profits Interest Units Grant” or the “Award”).  Underlined and capitalized captions in Items A through G below shall have the meanings therein ascribed to them.  Other capitalized terms used in this Agreement are defined in Section 16 of the Terms and Conditions.  Capitalized terms that are used but not defined in this Agreement shall have the meaning ascribed to them in the “Plan” (as defined below).

A.

Grant Date: [GRANT DATE].

B.

Plan: (under which Profits Interest Units Grant is granted): Omega Healthcare Investors, Inc. 2018 Stock Incentive Plan.

C.

Profits Interest Units: _______ Profits Interest Units. “Profits Interest Units” has the same meaning as “LTIP Units” as defined in the Limited Partnership Agreement, and  each Profits Interest Unit represents, on the Grant Date, one Unvested Profits Interest Unit,” which is one “Unvested LTIP Unit” as defined in and pursuant to the Limited Partnership Agreement, subject to adjustment as provided in the attached Terms and Conditions, and also represents the Partnership’s unsecured obligation to issue to the Recipient distributions described in Item E below.

D.

Vesting Schedule:  The Recipient shall become vested in a number of Profits Interest Units as and when determined pursuant to Exhibit 1. The Profits Interest Units which have become vested pursuant to the Vesting Schedule are herein referred to as the “Vested Profits Interest Units.

E.

Distributions:  The “LTIP Unit Distributions Participation Date” attributable to Profits Interest Units as defined in and pursuant to Section 15.4 of the Limited Partnership Agreement shall be [GRANT DATE], and as a result, with respect to distributions and allocations of Net Income and Net Loss that accrue on and after [GRANT DATE], the Recipient shall receive with respect to each Unvested Profits Interest Unit and each Vested Profits Interest Unit the same distributions and allocations of Net Income and Net Loss pursuant to the Limited Partnership Agreement that are paid to each “LP Unit” as defined therein.


F.

Non-Competition Provisions:  The Recipient acknowledges that if the Recipient is subject to any provisions then in effect in the employment agreement between the Recipient and the Company or an Affiliate that limit the ability of the Recipient to enter into competition with the Company or its Affiliates or to work for a business which is in a similar business to that of the Company or of an Affiliate, the Recipient will abide by such provisions.  Further, the Recipient agrees that if there is no such employment agreement or there are no such provisions in the employment agreement, during the Applicable Period, the Recipient  will not (except on behalf of or with the prior written consent of the Company, which consent may be withheld in Company’s sole discretion), within the Area, on the Recipient‘s own behalf, or in the service of or on behalf of others, and whether as an employee, a consultant or otherwise, provide managerial services or management consulting services substantially similar to those the Recipient provides for the Company or an Affiliate to any Competing Business.  As of the Grant Date, the Recipient acknowledges and agrees that the Recipient provides services to the Company throughout the Area.  

G.

Non-Solicitation Provisions:  The Recipient acknowledges that if the Recipient is subject to any provisions then in effect in the employment agreement between the Recipient and the Company or an Affiliate that limit the ability of the Recipient to solicit clients or employees of the Company or its Affiliates, the Recipient will abide by such provisions.  Further, the Recipient agrees that if there is no such employment agreement or there are no such provisions in the employment agreement, during the Applicable Period, the Recipient will not, on the Recipient’s own behalf or in the service of or on behalf of others:

(i) solicit any individual or entity which is an actual client of the Company or any of its Affiliates as of the Determination Date with whom the Recipient had direct material contact while the Recipient was an employee of the Company or an Affiliate, for the purpose of offering services substantially similar to those offered by the Company or an Affiliate, or

(ii)  solicit for employment with a Competing Business any person who is a management level employee of the Company or an Affiliate with whom the Recipient had contact during the then most recent year of the Recipient’s employment with the Company or an Affiliate.  

The Recipient shall not be deemed to be in breach of Item G(ii) solely because an employer for whom the Recipient performs services solicits, diverts, or hires a management level employee of the Company or an Affiliate, provided that the Recipient does not engage in the activity proscribed by Item G(ii).

H.

Acknowledgement:  The Recipient acknowledges and agrees that the Recipient’s agreement to and compliance with the provisions of this Agreement, including without limitation Item F and Item G above, are conditions to the effectiveness of the grant of the Award, and further acknowledges and agrees that the Recipient’s noncompliance with Item F or Item G above can result in a forfeiture and/or


recovery of all or part of the Award to the extent provided in the Vesting Schedule. The Recipient also acknowledges and agrees that the forfeitures and compensation recoveries provided for in this Agreement in connection with any breach during the Applicable Period by the Recipient of the Restrictive Provisions or the Intellectual Property Agreement shall not be the Company’s sole remedy, and nothing in this Agreement limits the Company’s right to seek damages, injunctive relief or other legal or equitable relief in case of any breach during the Applicable Period by the Recipient of the Restrictive Provisions or the Intellectual Property Agreement, except to the extent provided otherwise in the last paragraph of the Vesting Schedule.  In the event that any provision of this Agreement is determined by a court which has jurisdiction to be unenforceable in part or in whole, the court shall be deemed to have the authority to strike or sever any unenforceable provision, or any part thereof or to revise any provision to the minimum extent necessary to render the provision reasonable and then to enforce the provision to the maximum extent permitted by law.

IN WITNESS WHEREOF, the Partnership and the Recipient have executed and agree to be bound by this Agreement as of the Grant Date set forth above.

OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP

By: ​ ​

Title: ​ ​

THE RECIPIENT

By: ______________________________________

Name: ____________________________________


TERMS AND CONDITIONS TO THE
TIME-BASED PROFITS INTEREST UNITS AGREEMENT
PURSUANT TO
THE OMEGA HEALTHCARE INVESTORS, INC. 2018 STOCK INCENTIVE PLAN

Conditions to Grant of Profits Interest Units. As a condition of receiving the grant of Profits Interest Units hereunder, the Recipient must (a) execute the representations and warranties set forth on Exhibit 2 attached hereto, and deliver them to the Partnership within thirty (30) days of the Grant Date, and (b) file with the IRS within thirty (30) days of the Grant Date, a valid election under Code Section 83(b), in substantially the form of Exhibit 3 attached hereto, as to all of the Profits Interest Units.  The Recipient must also deliver to the Partnership, within thirty (30) days after the Grant Date, a copy of such election.  Failure to comply with the requirements of this Section shall result in the forfeiture of all the Profits Interest Units and the cancellation of this Agreement.

Issuance of Profits Interest Units.  The Partnership shall record in the name of the Recipient the number of Profits Interest Units (“LTIP Units,” as defined in the Limited Partnership Agreement”) awarded as of the Grant Date. The Partnership and the Recipient acknowledge and agree that the Profits Interest Units are hereby issued to the Recipient for the performance of services to or for the benefit of the Partnership and its Affiliates. If the Recipient is not already a partner of the Partnership pursuant to the Limited Partnership Agreement (defined therein as a “Partner”), the Partnership admits the Recipient as an “LTIP Unit Limited Partner” (as defined therein) and a Partner on the terms and conditions in this Agreement, the Plan and the Limited Partnership Agreement. Upon execution of this Agreement, the Recipient shall, automatically and without further action on the Recipient’s part, be deemed to be a signatory of and bound by the Limited Partnership Agreement. At the request of the Partnership, the Recipient shall execute the Limited Partnership Agreement or a counterpart signature page thereto.  

Rights as a Unitholder.  The Profits Interest Units shall be treated as a “profits interest” within the meaning of Revenue Procedure 93-27, and the Recipient shall be treated as having received the interest on the Grant Date as contemplated under Section 4 of Revenue Procedure 2001-43.  As the owner of the Profits Interest Units for income tax purposes, the Recipient shall take into account the Recipient’s distributive share of income, gain, loss, deduction and credit associated with the Profits Interest Units as determined in accordance with the terms of the Limited Partnership Agreement and this Agreement.

Restrictions on Transfer.  The Recipient shall not sell, pledge, assign, transfer or hypothecate, or otherwise dispose of any Profits Interest Units, whether outright or as security, with or without consideration, voluntary or involuntary, of all or any part of any right, title or interest in or to the Profits Interest Units, except as otherwise provided in the Limited Partnership Agreement. Any disposition not made in accordance with this Agreement shall be deemed null and void.  Any permitted transferee under this Section shall be bound by the terms of this Agreement and the Limited Partnership Agreement.

Tax Withholding. If and only if tax withholding applies with respect to the grant, vesting, ownership or disposition of Profits Interest Units, the Company or an Affiliate may withhold from


the Recipient’s wages, or require the Recipient to remit to the Partnership, the Company or an Affiliate, any applicable required tax withholding.

Change in Capitalization.

(a)The number and kind of units issuable under this Agreement shall be proportionately adjusted for any non-reciprocal transaction between the Partnership and the holders of partnership interests of the Partnership that causes the per unit value of the Profits Interest Units subject to the Award to change, such as a unit dividend, unit split, spinoff or rights offering (each an “Equity Restructuring”). No fractional shares shall be issued in making such adjustment.
(b)In the event of a merger, consolidation, reorganization, extraordinary dividend, spin-off, sale of substantially all of the Partnership’s assets, other change in capital structure of the Partnership, tender offer for Profits Interest Units (“LTIP Units,” as defined in the Limited Partnership Agreement), or a Change in Control, that in each case does not constitute an Equity Restructuring, the Committee shall take such action to make such adjustments with respect to the Profits Interest Units as the Committee, in its sole discretion, determines in good faith is necessary or appropriate and as is permitted by the Plan, including, without limitation, adjusting the number and class of units subject to the Award, substituting other securities, property or cash to replace the Award, all as determined in good faith by the Committee to have equivalent value to the Award, removing restrictions on the Award, or terminating the Award in exchange for the cash value determined in good faith by the Committee.  Any adjustment pursuant to this Section may provide, in the Committee’s discretion, for the elimination without payment of any fractional units that might otherwise be subject to the Award, but except as set forth in this Subsection and the Plan may not otherwise diminish the then value of the Award.
(c)All determinations and adjustments made by the Committee pursuant to this Section will be final and binding on the Recipient. Any action taken by the Committee need not treat all recipients of awards under the Plan equally.
(d)The existence of the Plan and the Profits Interest Unit Grant shall not affect the right or power of the Partnership to make or authorize any adjustment, reclassification, reorganization or other change in its capital or business structure, any merger or consolidation of the Partnership, any issue of debt or equity securities having preferences or priorities as to the Profits Interest Units or the rights thereof, the dissolution or liquidation of the Partnership, any sale or transfer of all or part of its business or assets, or any other corporate act or proceeding.

Governing Laws.  This Award shall be construed, administered and enforced according to the laws of the State of Maryland; provided, however, no Profits Interest Units shall be issued except, in the reasonable judgment of the Committee, in compliance with exemptions under applicable state securities laws of the state in which Recipient resides, and/or any other applicable securities laws.


Successors.  This Agreement shall be binding upon and inure to the benefit of the heirs, legal representatives, successors, and permitted assigns of the parties.

Notice.  Except as otherwise specified herein, all notices and other communications under this Agreement shall be in writing and shall be deemed to have been given if personally delivered or if sent by registered or certified United States mail, return receipt requested, postage prepaid, addressed to the proposed recipient at the last known address of the Recipient.  Any party may designate any other address to which notices shall be sent by giving notice of the address to the other parties in the same manner as provided herein.

Severability.  In the event that any one or more of the provisions or portion thereof contained in this Agreement shall for any reason be held to be invalid, illegal, or unenforceable in any respect, the same shall not invalidate or otherwise affect any other provisions of this Agreement, and this Agreement shall be construed as if the invalid, illegal or unenforceable provision or portion thereof had never been contained herein.

Entire Agreement.  This Agreement and the Limited Partnership Agreement, together with the terms and conditions set forth in the Plan, express the entire understanding and agreement of the parties with respect to the subject matter. In the event of a conflict between the terms of the Plan or the Limited Partnership Agreement and this Agreement, the Plan and the Limited Partnership Agreement shall govern.

Specific Performance.  In the event of any actual or threatened default in, or breach of, any of the terms, conditions and provisions of this Agreement, the party or parties who are thereby aggrieved shall have the right to specific performance and injunction in addition to any and all other rights and remedies at law or in equity, and all such rights and remedies shall be cumulative.

No Right to Continued Retention.  Neither the establishment of the Plan nor the Award shall be construed as giving Recipient the right to continued service with the Company or an Affiliate.

Tax Effects under 409A.  It is intended that the Award under this Agreement be exempt from Section 409A of the Internal Revenue Code (the “Code”) as a current grant of a profits interest as provided in Section 3 hereof.      

Headings.  Except as otherwise provided in this Agreement, headings used herein are for convenience of reference only and shall not be considered in construing this Agreement.  

16.Definitions.  As used in this Agreement:

Affiliate” means any person, firm, corporation, partnership, association or entity that, directly or indirectly or through one or more intermediaries, controls, is controlled by or is under common control with the Company.

Applicable Period” means:

(a)as to the Restrictive Provisions,

(i)the period of time that the Restrictive Provisions are in effect in accordance with the terms of the employment agreement then in effect between the Recipient and the Company or an Affiliate, or

(ii)  if there is no such employment agreement or there are no such provisions in the employment agreement, the period of the Recipient’s employment with the Company or an Affiliate, and with respect to the Non-Solicitation Provisions,  twelve (12) months thereafter, and with respect to the Non-Competition Provisions, six (6) months thereafter; and  

(b)  as to the Intellectual Property Agreement, the period of time that any breach of such agreement would be actionable by the Company or an Affiliate pursuant to the terms of such agreement.  

Area” means the states, areas and countries in which the Company or any of its Affiliates owns, acquires, develops, invests in, leases, finances the ownership of, or finances the operation of any skilled nursing facilities, senior housing, long-term care facilities, assisted living facilities, or other residential healthcare-related real estate.

Board” means the Board of Directors of the Company.

Business of the Company” means any business with the primary purpose of leasing assets to healthcare operators, or financing the ownership of or financing the operation of skilled nursing facilities, senior housing, long-term care facilities, assisted living facilities, or other residential healthcare-related real estate.        

Cause” shall have the meaning set forth in the employment agreement then in effect between the Recipient and the Company or an Affiliate, or, if there is none, then Cause shall mean the occurrence of any of the following events:

(a)willful refusal by the Recipient to follow a lawful direction of any person to whom the Recipient reports or the Chief Executive Officer of the Company, provided the direction is not materially inconsistent with the duties or responsibilities of the Recipient’s position with the Company or an Affiliate, which refusal continues after such person or the Chief Executive Officer of the Company has again given the direction in writing;

(b)willful misconduct or reckless disregard by the Recipient of the Recipient’s duties or with respect to the interest or material property of the Company or an Affiliate;

(c)material breach by the Recipient of any of the Restrictive Provisions;

(d)material breach by the Recipient of any provision of the Intellectual Property Agreement;

(e)any act by the Recipient of fraud against, material misappropriation from or significant dishonesty to either the Company or an Affiliate, or any other party, but in the latter case only if in the reasonable opinion of the Chief Executive Officer of the Company,


such fraud, material misappropriation, or significant dishonesty could reasonably be expected to have a material adverse impact on the Company or its Affiliates; or

(f)commission by the Recipient of a felony as reasonably determined by the Chief Executive Officer of the Company.

Change in Control” means any one of the following events which occurs following the Grant Date:

(a)the acquisition within a twelve (12) month period, directly or indirectly, by any “person” or “persons” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than the Company or any employee benefit plan of the Company or an Affiliate, or any corporation or other entity pursuant to a reorganization, merger or consolidation, of equity securities of the Company that in the aggregate represent thirty percent (30%) or more of the total voting power of the Company’s then outstanding equity securities;
(b)the acquisition, directly or indirectly, by any “person” or “persons” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than the Company or any employee benefit plan of the Company or an Affiliate, or any corporation or other entity pursuant to a reorganization, merger or consolidation of equity securities of the Company, resulting in such person or persons holding equity securities of the Company that, together with equity securities already held by such person or persons, in the aggregate represent more than fifty percent (50%) of the total fair market value or total voting power of the Company’s then outstanding equity securities;
(c)individuals who as of the date hereof, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least two-thirds of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board;
(d)a reorganization, merger or consolidation, with respect to which persons who were the holders of equity securities of the Company immediately prior to such reorganization, merger or consolidation, immediately thereafter, own equity securities of the surviving entity representing less than fifty percent (50%) of the combined ordinary voting power of the then outstanding voting securities of the surviving entity; or
(e)the acquisition within a twelve (12) month period, directly or indirectly, by any “person” or “persons” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than any corporation or other

entity pursuant to a reorganization, merger or consolidation, of assets of the Company that have a total gross fair market value equal to or more than eighty-five percent (85%) of the total gross fair market value of all of the assets of the Company immediately before such acquisition.

Notwithstanding the foregoing, no Change in Control shall be deemed to have occurred for purposes of this Agreement (i) unless the event also constitutes a “change in the ownership or effective control of the corporation or in the ownership of a substantial portion of the assets of the corporation” within the meaning of Code Section 409A(a)(2)(v), or (ii) by reason of any actions or events in which the Recipient participates in a capacity other than in his capacity as an officer, employee, or director of the Company or an Affiliate.

Competing Business” means any person, firm, corporation, joint venture, or other business that is engaged in the Business of the Company.

Determination Date” means with respect to determining compliance with a covenant of this Agreement (a) while the Recipient remains employed by the Company or an Affiliate, the date as of which compliance is being determined, and (b) after the Recipient’s termination of employment, the date of the Recipient’s termination of employment.

Good Reason” shall have the meaning set forth in the employment agreement then in effect between the Recipient and the Company or an Affiliate, or, if there is none, then Good Reason shall mean the occurrence of an event listed in (a) through (c) below:

(a)the Recipient experiences a material diminution of the Recipient’s responsibilities of the Recipient’s position, as reasonably modified by any person to whom the Recipient reports or the Chief Executive Officer of the Company from time to time, such that the Recipient would no longer have responsibilities substantially equivalent to those of other employees holding equivalent positions at companies with similar revenues and market capitalization;

(b)the Company or the Affiliate which employs the Recipient reduces the Recipient’s annual base salary or annual bonus opportunity at high, target or threshold performance as a percentage of annual base salary; or

(c)the Company or the Affiliate which employs the Recipient requires the Recipient to relocate the Recipient’s primary place of employment to a new location that is more than fifty (50) miles from its current location (determined using the most direct driving route), without the Recipient’s consent;

provided however, as to each event in Subsection (a) through (c),

(i)the Recipient gives written notice to the Company within ten (10) days following the event or receipt of notice of the event of the Recipient’s objection to the event;

(ii)the Company or the Affiliate which employs the Recipient fails to remedy the event within ten (10) days following the Recipient’s written notice; and


(iii)the Recipient terminates his employment within thirty (30) days following the Company’s and the Affiliate’s failure to remedy the event.

Intellectual Property Agreement” means that certain agreement entitled “Intellectual Property Agreement” previously entered into between the Company and the Recipient.

Limited Partnership Agreement” means the Second Amended and Restated Agreement of OHI Healthcare Properties Limited Partnership, dated as of April 1, 2015, as it may be amended or any successor agreement thereto.

Non-Competition Provisions” means the provisions under the title “Non-Competition Provisions” heading in Item F above of this Agreement.

Non-Solicitation Provisions” means the provisions under the title “Non-Solicitation Provisions” heading in Item G above of this Agreement.

Release” means a comprehensive release, covenant not to sue, and non-disparagement agreement from the Recipient in favor of the Company, its executives, officers, directors, Affiliates, and all related parties, in the form provided by the Company (which, if the Recipient is a party to an employment agreement with the Company or an Affiliate and the Recipient’s right to receive severance pay in connection with a qualifying termination of employment thereunder is contingent on the execution and non-revocation of a release agreement in substantially the form attached to the employment agreement, will be substantially the same form of release agreement attached to the employment agreement); provided, however, the Company may make any changes to the Release as it determines to be necessary only to ensure that the Release is enforceable under applicable law.

Restrictive Provisions” means the Non-Competition Provisions and the Non-Solicitation Provisions.

Retirement” means voluntary resignation by a Recipient after having reached at least age sixty-two (62) and having performed at least ten (10) years of service with the Company, any subsidiary and/or any company that is acquired directly or indirectly by the Company.  In addition, a Recipient must give at least six (6) months prior written notice of resignation for such voluntary resignation to qualify as “Retirement.”  The Recipient may give the required notice before satisfying the age and service requirements for Retirement, provided the Recipient satisfies the age and service requirements as of the effective date of Retirement.


EXHIBIT 1

VESTING SCHEDULE

A.

Active Employee.  Except as provided in the remainder of this Vesting Schedule, the Profits Interest Units shall become Vested Profits Interest Units in accordance with the following schedule:


Date

Percentage of Profits Interest Units

which are Vested Profits Interest Units

December 31, [YEAR]

100%

; provided the Recipient must remain an employee, director or consultant of the Company or an Affiliate through the indicated date set forth above to vest in accordance with the schedule above; provided further, if during the Applicable Period and while the Recipient remains an employee, director or consultant of the Company or an Affiliate, the Recipient breaches the Restrictive Provisions or the Intellectual Property Agreement, the Board is permitted to require the Recipient to return to the Company any Profits Interest Units which vested within one year before the breach, or if such Profits Interest Units had been sold in an arm’s length transaction or redeemed by the Recipient, the proceeds of such sale or redemption as determined by the Board.  The amount of the recovery shall be determined without regard to any taxes paid by or withheld from the wages of the Recipient unless the Board shall determine otherwise.  Any subsequent provision of this Vesting Schedule providing for vesting in the specified circumstances shall not override the compensation recovery provisions of this Item A.

B.

Disability, Good Reason or without Cause Termination.  Except as provided in Item F below, if , in the year set forth in the following schedule, the Recipient ceases services as an employee, director or consultant of the Company and all Affiliates due to the Recipient’s Disability, the Recipient’s resignation from the Company and all Affiliates for Good Reason, or the termination of the Recipient’s employment by the Company and its Affiliates without Cause (each such event referred to as a “Qualifying Termination”), then the percentage of the Profits Interest Units in the following schedule (rounded to the closest whole number of Profits Interest Units) shall become Vested Profits Interest Units as of the earlier of December 31, [YEAR] or the date of a Change in Control (the “Applicable Post-Termination Vesting Date”), subject to the Release requirement below:


Year of Qualifying Termination

Percentage of Profits Interest Units

which are Vested Profits Interest Units

[YEAR 1]

331/3%

[YEAR 2]

662/3%

[YEAR 3]

100%


; provided however, that as a condition to such vesting, the Recipient shall be required to execute within the twenty-one (21) day period provided therein (forty-five (45) days in the case of a group termination) and not revoke with the seven (7) day revocation period provided therein, the Release, which the Company shall provide to the Recipient as soon as feasible but not later than thirty (30) days following the Qualifying Termination, and provided further, that such vesting shall not occur if before the earlier of the Applicable Post-Termination Vesting Date or the end of the Applicable Period, the Recipient breaches any of the Restrictive Provisions or the Intellectual Property Agreement, and in such event, all Profits Interest Units shall be immediately forfeited as of the date of such breach.

C.

Retirement. Except as provided in Item F below, if the Recipient ceases services as an employee of the Company and all Affiliates due to Retirement in the year set forth in the following schedule, then the percentage of the Profits Interest Units in the following schedule (rounded to the closest whole number of Profits Interest Units) shall become Vested Profits Interest Units as of the Applicable Post-Termination Vesting Date, subject to the Release requirement below:


Year of Retirement

Percentage of Profits Interest Units

which are Vested Profits Interest Units

[YEAR 1]

0%

[YEAR 2]

100%

[YEAR 3]

100%

; provided however, that as a condition to such vesting, the Recipient shall be required to execute within the twenty-one (21) day period provided therein (forty-five (45) days in the case of a group termination) and not revoke with the seven (7) day revocation period provided therein, the Release, which the Company shall provide to the Recipient as soon as feasible but not later than thirty (30) days following the date of Retirement, and provided further, that such vesting shall not occur if before the earlier of the Applicable Post-Termination Vesting Date or the end of the Applicable Period, the Recipient breaches any of the Restrictive Provisions or the Intellectual Property Agreement, and in such event, all Profits Interest Units shall be immediately forfeited as of the date of such breach.

D.

Death after Qualifying Termination or Retirement. Except as provided in Item F below, if Item B or C of this Vesting Schedule applies and the Recipient thereafter dies before the date vesting occurs pursuant to Item B or C, then the vesting there provided shall be accelerated to the date of the Recipient’s death; provided however, that such vesting shall not occur if during the Applicable Period and before the date of death, the Recipient breached any of the Restrictive Provisions or the Intellectual Property Agreement, and in such event, all Profits Interest Units shall be immediately forfeited as of the date of such breach.  

E.

Death while Employed.  Except as provided in Item F below, if the Recipient ceases services as an employee, director or consultant of the Company and all Affiliates due to the Recipient’s death in the year set forth in the following schedule, then the percentage of


the Profits Interest Units in the following schedule (rounded to the closest whole number of Profits Interest Units) shall become Vested Profits Interest Units as of the date of death:


Year of Death

Percentage of Profits Interest Units

which are Vested Profits Interest Units

[YEAR 1]

331/3%

[YEAR 2]

662/3%

[YEAR 3]

100%

; provided however, that such vesting shall not occur if during the Applicable Period and before the date of death, the Recipient breached any of the Restrictive Provisions or the Intellectual Property Agreement, and in such event, all Restricted Stock Units shall be immediately forfeited as of the date of such breach.

F.

Change in Control.  Notwithstanding Items B through E of this Vesting Schedule, if a Change in Control occurs on or after the Grant Date and on or before December 31, [YEAR], and (i) within sixty (60) days before the Change in Control or (ii) after the Change in Control, the Recipient incurs a Qualifying Termination, ceases services as an employee of the Company and all Affiliates due to the Recipient’s Retirement (subject, in the case of such Qualifying Termination or Retirement, to the requirement that the Recipient shall be required to execute within the twenty-one (21) day period provided therein (forty-five (45) days in the case of a group termination) and not revoke with the seven (7) day revocation period provided therein, the Release, which the Company shall provide to the Recipient as soon as feasible but not later than thirty (30) days following the Qualifying Termination or Retirement), or ceases services as an employee, director or consultant of the Company and all Affiliates due to the Recipient’s death, then all Profits Interest Units which have not previously become Vested Profits Interest Units pursuant to any of Items B through E shall become Vested Profits Interest Units as of the later of the date of the Change in Control or the date of the Qualifying Termination, Retirement or death, subject to the foregoing Release requirement if applicable.

G.

Voluntary Resignation or Cause Termination.  Profits Interest Units which have not become Vested Profits Interest Units as of the Recipient’s cessation of services as an employee, director, or consultant of the Company and all Affiliates, except as provided in Items B through F of this Vesting Schedule, shall be forfeited.  Further, if (a) before a Change in Control, the Recipient ceases services as an employee, director or consultant of the Company and all Affiliates due to (I) the Recipient’s voluntary resignation without Good Reason (and not due to Disability or Retirement) or (II) the termination of the Recipient’s employment by the Company and its Affiliates for Cause, and (b) during the Applicable Period, the Recipient breaches the Restrictive Provisions or the Intellectual Property Agreement, the Board is permitted to require the Recipient to return to the Company any Profits Interest Units that vested within one year before the Recipient’s cessation of services, or if such Profits Interest Units had been sold in an arm’s length transaction or redeemed by the Recipient, the proceeds of such sale or redemption as determined by the Board.  The amount of the recovery shall be determined without regard


to any taxes paid by or withheld from the wages of the Recipient unless the Board shall determine otherwise.

H.

General Forfeiture Provisions.  Profits Interest Units which have not become Vested Profits Interest Units as of the earliest of (i) December 31, [YEAR], (ii) except as provided in Items B through F of this Vesting Schedule, as of the Recipient’s cessation of services as an employee, director, or consultant of the Company and all Affiliates, or (iii) the date provided in Item F, shall be forfeited, and once a forfeiture occurs no provision of this Vesting Schedule shall be construed to reinstate the forfeiture.  The forfeitures and compensation recoveries provided for in this Agreement in connection with any breach during the Applicable Period by a Recipient of the Restrictive Provisions or the Intellectual Property Agreement shall not be the Company’s sole remedy, and nothing in this Agreement limits the Company’s right to seek damages, injunctive relief or other legal or equitable relief in case of any such breach; provided, however, if the Recipient is not a party to an employment agreement with the Company or an Affiliate as of the date of termination of employment and the Recipient ceases services as an employee, director or consultant of the Company and all Affiliates due to a Qualifying Termination or Retirement, the Company’s sole remedy with respect to a breach by the Recipient during the Applicable Period of the Non-Competition Provisions will be the forfeiture provided in Item B or Item C, as applicable, of this Vesting Schedule; provided further, such limitation to the Company’s remedies shall not apply to the Recipient’s breach during the Applicable Period of the Non-Solicitation Provisions or the Intellectual Property Agreement.

I.

Fractional Units.  If any calculation in this Vesting Schedule results in a fractional number of Vested Profits Interest Units, the number of Vested Profits Interest Units shall be rounded to the closest whole number.


EXHIBIT 2

REPRESENTATIONS AND WARRANTIES OF THE RECIPIENT

In connection with the grant of the Profits Interest Units pursuant to the Agreement, the Recipient hereby represents and warrants to the Partnership that:

1.The Recipient is acquiring the Profits Interest Units for the Recipient’s own account with the present intention of holding the Profits Interest Units for investment purposes and not with a view to distribute or sell the Profits Interest Units, except in compliance with federal securities laws or applicable securities laws of other jurisdictions;
2.The Recipient acknowledges that the Profits Interest Units have not been registered under the Securities Act of 1933 (the “1933 Act”) or applicable securities laws of other jurisdictions and that the Profits Interest Units will be issued to the Recipient in reliance on exemptions from the registration requirements provided by Sections 3(b) or 4(2) of the 1933 Act and the rules and regulations promulgated thereunder and applicable securities laws of other jurisdictions and in reliance on the Recipient’s representations and agreements contained herein;
3.The Recipient is an employee of the Partnership or an Affiliate;
4.The Recipient acknowledges that the Profits Interest Units are subject to the restrictions contained in the Limited Partnership Agreement, and the Recipient has received and reviewed a copy of the Limited Partnership Agreement;
5.The Recipient has had the opportunity to ask questions of and receive answers from the Partnership and any person acting on its behalf concerning the terms and conditions of the Profits Interest Units awarded hereunder and has had full access to such other information concerning the Partnership and its Affiliates as the Recipient may have requested in making the Recipient’s decision to invest in the Profits Interest Units being issued hereunder;
6.The Recipient has such knowledge and experience in financial and business matters that the Recipient is capable of evaluating the merits and risks of the acquisition of the Profits Interest Units hereunder and the Recipient is able to bear the economic risk, if any, of such acquisition;
7.The Recipient has only relied on the advice of, or has consulted with, the Recipient’s own legal, financial and tax advisors, and the determination of the Recipient to acquire the Profits Interest Units pursuant to this Agreement has been made by the Recipient independent of any statements or opinions as to the advisability of such acquisition or as to the properties, business, prospects or condition (financial or otherwise) of the Partnership or its Affiliates which may have been made or given by any other person or by any agent or employee of such person and independent of the fact that any other person has decided to become a holder of Profits Interest Units;

8.None of the Partnership or any of its Affiliates has made any representation or agreement to the Recipient with respect to the income tax consequences of the issuance, ownership or vesting of Profits Interest Units or the transactions contemplated by this Agreement (including without limitation the making of an election under Code Section 83(b)), and the Recipient is in no manner relying on the Partnership or any Affiliate or their representatives for an assessment of tax consequences to the Recipient. The Recipient is advised to consult with the Recipient’s own tax advisor with respect to the tax consequences;  
9.The Recipient is not acquiring the Profits Interest Units as a result of, or subsequent to, any publicly disseminated advertisement, article, sales literature, publication, broadcast or any public seminar or meeting or any solicitation nor is the Recipient aware of any offers made to other persons by such means;
10.The Recipient understands and agrees that if certificates representing the Profits Interest Units are issued, such certificates may bear such restrictive legends as the Partnership or its legal counsel may deem necessary or advisable under applicable law or pursuant to this Agreement;  
11.The Profits Interest Units cannot be offered for sale, sold or transferred by the Recipient other than pursuant to: (i) an effective registration under the 1933 Act or in a transaction otherwise in compliance with the 1933 Act; and (ii) evidence satisfactory to the Partnership of compliance with the applicable securities laws of other jurisdictions.  The Partnership shall be entitled to rely upon an opinion of counsel satisfactory to it with respect to compliance with the above laws;  
12.The Partnership shall be under no obligation to register the Profits Interest Units or to comply with any exemption available for sale of the Profits Interest Units without registration or filing;
13.The Recipient represents that the Recipient is an “accredited investor” as that term is defined in Rule 501 of Regulation D of the 33 Act; specifically, either [(a) the Recipient is an executive officer of the Partnership or of Omega Healthcare Investors, the general partner of the Partnership, or  (b) the Recipient has (i) had an individual income in excess of $200,000 in each of the two most recent years or joint income with the Recipient’s spouse or “spousal equivalent” (meaning your cohabitant occupying a relationship generally equivalent to that of a spouse) in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year, (ii) the Recipient’s net worth or joint net worth with the Recipient’s spouse or spousal equivalent exceeds $1,000,000 (and for purposes of calculating net worth under this paragraph, the Recipient’s primary residence is not included as an asset; indebtedness that is secured by the primary residence, up to the estimated fair market value of the primary residence is not included as a liability (except that if the amount of such indebtedness outstanding exceeds the amount outstanding within the last 60 days, other than as a result of the acquisition of the primary residence, the amount of such excess is  included as a liability)), or (iii) the Recipient holds in good standing one of the following professional licenses: the General Securities Representative license (Series 7), the Private Securities

Offerings Representative license (Series 82), or the Investment Adviser Representative license (Series 65)]; and
14.The Recipient agrees to furnish any additional information requested to assure compliance with applicable securities laws in connection with the issuance or holding of Profits Interest Units. The Recipient acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with applicable federal and state laws. Notwithstanding anything to the contrary herein, the Plan shall be administered and the grant of Profits Interest Units is made only in such manner as to conform to such laws. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such laws.  By execution below, the Recipient acknowledges that the Recipient has received a copy of the Agreement, the Limited Partnership Agreement and the Plan.

RECIPIENT

​ ​​ ​​ ​​ ​
SignatureDateName


EXHIBIT 3
SECTION 83(b) ELECTION

The undersigned hereby elects to be taxed pursuant to Section 83(b) of the Internal Revenue Code of 1986 (the “Code”) with respect to the property described below and supplies the following information in accordance with the regulations promulgated thereunder:

1.

The name, address and taxpayer identification number of the undersigned is:

________________________

________________________

________________________

Taxpayer I.D. No.:  ________________________

2.

Description of property with respect to which the election is being made:

_______ Profits Interest Units of OHI Healthcare Properties Limited Partnership (the Profits Interest Units,” defined in the OHI Healthcare Properties Limited Partnership as “LTIP Units”).

3.The date on which the property was transferred:

The Profits Interest Units were transferred on [GRANT DATE].

4.The taxable year to which this election relates is calendar year [YEAR].

5.The nature of the restriction(s) to which the property is subject is:

The Profits Interest Units shall vest in increments on specified vesting dates or upon certain vesting events subsequent to the property transfer date, provided that the taxpayer continues to perform services for OHI Healthcare Properties Limited Partnership (the “Partnership”) or an affiliate.  In the event the taxpayer ceases to perform services for the Partnership and its affiliates under certain circumstances prior to the final vesting date, any unvested Profits Interest Units shall be forfeited back to the Partnership.

6.

Fair Market Value:

Because the Profits Interest Units constitute a profits interest, the grant of the interest is not taxable under Code Section 83 pursuant to Revenue Procedure 93-27 and Revenue Procedure 2001-43.  Therefore, the taxpayer is reporting that the fair market value at the time of transfer (determined without regard to any restrictions other than restrictions which by their terms will never lapse) of the property with respect to which this election is being made as $0 per Profits Interest Unit.

7. Amount paid for property:

The taxpayer did not pay for the Profits Interest Units.

8. Furnishing statement to the person for whom services are performed:

A copy of this statement has been furnished to the Partnership.

By:​ ​

Date: ________



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/17/22
For Period end:12/31/214,  4/A,  5,  8-K
4/1/153,  4,  4/A,  S-8
 List all Filings 


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/12/24  Omega Healthcare Investors Inc.   10-K       12/31/23  156:32M
 2/14/23  Omega Healthcare Investors Inc.   10-K       12/31/22  150:30M
11/03/22  Omega Healthcare Investors Inc.   10-Q        9/30/22  112:16M
 8/02/22  Omega Healthcare Investors Inc.   10-Q        6/30/22  110:16M
 5/03/22  Omega Healthcare Investors Inc.   10-Q        3/31/22  103:13M


42 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/27/22  Omega Healthcare Investors Inc.   8-K:5,7,9   1/27/22   12:443K                                   Toppan Merrill/FA
 5/20/21  Omega Healthcare Investors Inc.   8-K:8,9     5/20/21   14:1M                                     Toppan Merrill/FA
 5/04/21  Omega Healthcare Investors Inc.   8-K:1,2,9   4/30/21   12:2.8M                                   Toppan Merrill/FA
 3/10/21  Omega Healthcare Investors Inc.   8-K:1,2,9   3/10/21   14:1M                                     Toppan Merrill/FA
 2/22/21  Omega Healthcare Investors Inc.   10-K       12/31/20  142:28M
11/03/20  Omega Healthcare Investors Inc.   10-Q        9/30/20  113:19M
10/09/20  Omega Healthcare Investors Inc.   8-K:1,2,9  10/07/20   16:1.1M                                   Toppan Merrill/FA
 2/28/20  Omega Healthcare Investors Inc.   10-K       12/31/19  159:33M
12/20/19  Omega Healthcare Investors Inc.   8-K:5,9    12/16/19   13:736K                                   Toppan Merrill/FA
11/08/19  Omega Healthcare Investors Inc.   10-Q        9/30/19  109:16M
 9/20/19  Omega Healthcare Investors Inc.   8-K:1,2,9   9/17/19   16:1.1M                                   Toppan Merrill/FA
 2/26/19  Omega Healthcare Investors Inc.   10-K       12/31/18  157:34M
 1/04/19  Omega Healthcare Investors Inc.   8-K:1,8,9   1/02/19    2:670K                                   Toppan Merrill/FA
 8/08/18  Omega Healthcare Investors Inc.   10-Q        6/30/18   98:11M                                    Toppan Merrill/FA
 6/11/18  Omega Healthcare Investors Inc.   8-K:5,9     6/11/18    2:255K
 2/23/18  Omega Healthcare Investors Inc.   10-K       12/31/17  152:17M                                    Toppan Merrill/FA
 8/09/17  Omega Healthcare Investors Inc.   10-Q        6/30/17  108:9.1M                                   Toppan Vite NY Inc./FA
 5/05/17  Omega Healthcare Investors Inc.   10-Q        3/31/17  100:8.7M                                   Toppan Vite NY Inc./FA
 4/04/17  Omega Healthcare Investors Inc.   8-K:1,2,9   4/04/17   15:2M                                     Toppan Vite NY Inc./FA
 2/24/17  Omega Healthcare Investors Inc.   10-K       12/31/16  141:19M                                    Toppan Vite NY Inc./FA
11/08/16  Omega Healthcare Investors Inc.   10-Q        9/30/16  103:10M                                    Toppan Vite NY Inc./FA
 8/05/16  Omega Healthcare Investors Inc.   10-Q        6/30/16  103:9.7M                                   Toppan Vite NY Inc./FA
 7/12/16  Omega Healthcare Investors Inc.   8-K:1,2,9   7/12/16   15:2.1M                                   Toppan Vite NY Inc./FA
 5/06/16  Omega Healthcare Investors Inc.   10-Q        3/31/16   97:8.4M                                   Toppan Vite NY Inc./FA
 2/29/16  Omega Healthcare Investors Inc.   10-K       12/31/15  134:16M                                    Toppan Vite NY Inc./FA
11/12/15  OHI Asset (IN) Monticello, LLC    S-4                   24:4.4M                                   Toppan Vite NY Inc./FA
11/12/15  Seguin Texas Property, L.L.C.     S-4/A      11/10/15    6:1.9M                                   Toppan Vite NY Inc./FA
11/06/15  Omega Healthcare Investors Inc.   10-Q        9/30/15  101:10M                                    Toppan Vite NY Inc./FA
10/06/15  Yuba Aviv, L.L.C.                 S-4                   38:5.9M                                   Toppan Vite NY Inc./FA
 9/29/15  Omega Healthcare Investors Inc.   8-K:1,2,8,9 9/23/15    3:907K                                   Toppan Vite NY Inc./FA
 9/03/15  Omega Healthcare Investors Inc.   S-3ASR      9/03/15    7:534K                                   Toppan Vite NY Inc./FA
 5/08/15  Omega Healthcare Investors Inc.   10-Q        3/31/15   91:13M                                    Toppan Vite NY Inc./FA
 4/16/15  Tulare County Property, L.L.C.    S-4                   78:7.6M                                   Toppan Vite NY Inc./FA
 4/03/15  Omega Healthcare Investors Inc.   8-K:1,2,5,8 3/31/15   18:8.3M                                   Toppan Vite NY Inc./FA
 3/24/15  Omega Healthcare Investors Inc.   8-K:1,2,9   3/18/15    3:888K                                   Toppan Vite NY Inc./FA
 2/27/15  Omega Healthcare Investors Inc.   10-K       12/31/14  132:27M                                    Toppan Vite NY Inc./FA
 9/11/14  Omega Healthcare Investors Inc.   8-K:1,2,9   9/11/14    3:854K                                   Toppan Vite NY Inc./FA
 8/06/14  Omega Healthcare Investors Inc.   10-Q        6/30/14   81:15M                                    Toppan Vite NY Inc./FA
 3/11/14  Omega Healthcare Investors Inc.   8-K:1,2,9   3/11/14    3:851K                                   Toppan Vite NY Inc./FA
 8/05/13  Omega Healthcare Investors Inc.   10-Q        6/30/13  115:16M                                    Toppan Vite NY Inc./FA
11/07/12  Omega Healthcare Investors Inc.   10-Q        9/30/12   65:13M                                    Toppan Vite NY Inc./FA
 5/02/11  Aviv REIT, Inc.                   S-4         4/29/11  387:17M                                    Donnelley … Solutions/FA
Top
Filing Submission 0000888491-22-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 9:11:45.5pm ET